Finbold’s Coronavirus Research Index shows that the US is leading the way in Covid-19 with 106 studies registered as of today, 16 April. China comes in second with 68 studies, with France in close third with 66 studies.
This marks a dramatic shift from ten days ago when the China was leading the way with 60 studies, and the US trailed in second with 49 studies. France remained in third with only 26 studies, meaning it has registered 40 more studies in less than two weeks.
The index uses data from studies reported as ‘active’ on clinicaltrials.gov; it includes all studies labelled as recruiting, not yet recruiting, active, but not recruiting and enrolling by invitation.